https://www.selleckchem.com/pr....oducts/wy-14643-piri
This evidence-based systematic review synthesizes and critically appraises current clinical recommendations and advances in the diagnosis and treatment of BIA-ALCL. This review also aims to broaden physician awareness across diverse specialties, particularly among general practitioners, breast surgeons, surgical oncologists, and other clinicians who may encounter patients with breast implants in their practice. BIA-ALCL is an emerging and treatable immune cell cancer definitively linked to textured-surface breast implant
Like
Comment
Share
